OtherMolecular autism2020

Transcriptional consequences of MBD5 disruption in mouse brain and CRISPR-derived neurons.

Catarina M Seabra, Tatsiana Aneichyk, Serkan Erdin and 12 others

PMID 32503625

WHAT IT FOUND

MBD5 reduction alters gene expression differently in each brain region and cell type.

There is no single shared pathway, meaning effects depend on the specific cellular context. This complicates finding a universal mechanism for 2q23.1 syndrome.

Key findings

01Gene expression changes caused by MBD5 reduction were largely distinct across cortex, cerebellum, and striatum, with minimal overlap in differentially expressed genes.

02Analysis of human iPSC-derived neurons showed limited overlap with mouse brain data, reinforcing that MBD5 effects are highly context-dependent rather than consistent across cell types.

03Cortical gene expression changes were enriched for modules related to ciliary function, suggesting a potential early developmental impact on cilia in this region.

STILL TO COME

How it was doneWhat they found

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

The study uses animal and cell models, not humans with the syndrome, so direct clinical applicability is limited. The transcriptional changes observed were modest and subtle, making it difficult to detect clear patterns. The analysis was performed at a single time point (8 weeks in mice), missing critical early developmental windows. There was no consistent pathway disrupted across all models, suggesting a complex, context-dependent mechanism that is hard to generalize.

Declared interests

The authors declared no conflicts of interest. The work was supported by the National Institute of General Medical Sciences and the National Institute of Neurological Disorders and Stroke.

The easy way to misread this

Do not assume that MBD5 disruption affects the same biological pathways in all patients or all brain regions. The lack of a shared signature across models means that findings in one cell type or region may not translate to another.

Read it on PubMed →


The study

Participants
10 mice and 8 wild-type controls; 3 edited and 3 control cell lines
Certainty of evidence
Low

Browse

    Cite

    Catarina M Seabra, Tatsiana Aneichyk, Serkan Erdin, et al. Transcriptional consequences of MBD5 disruption in mouse brain and CRISPR-derived neurons. Molecular autism. 2020.

    Read the original